SARS-CoV-2 Rapid Antigen Test 2.0 Nasal

IVD For in vitro diagnostic use.
SARS-CoV-2 Rapid Antigen Test 2.0 Nasal
Convenient sampling, quick results.

More convenient and less invasive testing for SARS-CoV-2 using nasal samples in symptomatic and asymptomatic individuals. Enhanced performance thanks to an improved capturing antibody and buffer composition.

The SARS-CoV-2 Rapid Antigen Test 2.0 Nasal provides rapid results for fast decision making at the Point of Care. Nasal sampling is less invasive than taking a sample from the nasopharynx which can reduce patient discomfort. Nasal swab samples may be self-collected by patients under supervision, offering further protection for healthcare professionals.

Key benefits
  • Enhanced performance compared to previous version: 95.80% relative sensitivity and 100.00% relative specificity1
  • Detection of SARS-CoV-2 infection in symptomatic and asymptomatic individuals1
  • Optimized composition to detect antigens against several dominant variants of the virus1
  • No instrument required
  • Access to testing in areas where laboratory testing is not available
  • Rapid answers in only 15 minutes
  • Nasal swab for quick and convenient specimen collection
  • Data matrix code on each test device for facilitated result sharing

Performing a test

Simple to perform and fast results within 15 – 30 min*

sars-cov-2-rapid-antigen-test nasal  2.0 step 1
Collection of nasal sample

While rotating the swab, insert the swab 2 cm (slightly less than 1 inch) parallel to the palate (not upwards) towards the throat into one nostril until resistance is met at turbinates. Do not apply pressure. Rotate the swab 4 times for about 15 seconds in total against the nasal wall and remove it from the nostril. Repeat in the other nostril using the same swab.

sars-cov-2-rapid-antigen-test nasal  2.0 step 2
Sample preparation

Insert the swab into an extraction buffer tube. While squeezing the buffer tube, stir the swab at least 10 times. Remove the swab while squeezing the sides of the tube to extract the liquid from the swab. Press the nozzle cap tightly onto the tube.

sars-cov-2-rapid-antigen-test nasal  2.0 step 3
Performing a test

Apply 4 drops of extracted specimen to the specimen well of the test device.

WARNING! Dispense the specimen at 90 degree angle to allow for free-falling drops drops and avoid bubbles.

sars-cov-2-rapid-antigen-test nasal  2.0 step 4
Read the results

Read the test result at 15 to 30 minutes.

WARNING! Test results that are read before 15 minutes or after 30 minutes may be incorrect. 

WARNING! Failure to squeeze the tube can lead to incorrect results.

* Before using the SARS-CoV-2 Rapid Antigen Test 2.0 Nasal, carefully read the Instructions for Use and all included warnings and precautions.

Interpresting results

Test results are quick and easy to read

rapid antigen test nasal 2.0 positive result
Positive test result

If both colored lines C and T are visible, even if they are faint or not uniform, the test result is positive. This means the test detected the virus protein in the sample. The tested person is very likely infected with SARS-CoV-2.

Control line C: Indicates that the test is working correctly
Test line T: Visibile if SARS-CoV-2 antigen was detected

rapid antigen test nasal 2.0 negative result
Negative test result

A visible control line C alone means the test worked correctly. The test result is negative. No virus protein could be detected in the sample. The tested person is unlikely infected with SARS-CoV-2.

rapid antigen test nasal 2.0 error result
Invalid test result

If a control line (C) is not visible, or only the line marked with a T, the result must be considered invalid. The test is not working correctly and you should perform another test using a different test kit.

Test kit information

Each kit contains 25 individually packaged, ready-to-use tests.

The following components are needed for a test and included in the kit:

  • Test device (individually in a foil pouch with desiccant)
  • Extraction buffer tube and buffer tube rack
  • Nozzle cap
  • Sterile swab
  • Instructions for Use and Quick Reference Guide
rapid antigen test nasal 2.0 kit
Digital connectivity

The SARS-CoV-2 Rapid Antigen Test 2.0 Nasal is equipped with a 2D data matrix code and a unique identifier printed on each test cassette. The 2D code is compliant with the common industry standard GS1 and thus can be read and interpreted by any IT system compatible with standard 2D data matrix codes.

Data matrix code

The 2D data matrix code is unique to each test device.
The following elements are encoded in a digitally readable format:

  • Lot number
  • Expiry date
  • GTIN (Global Trade Item Number)
  • Reference to source entity (i.e. production factory identification)
  • Serial number (i.e. 6-digit ID printed on the test cassette - unique per lot range)
rapid antigen test device



The unique identification of each test device enables a one to one assignment of test results to individual persons. This facilitates storage of test results under the respective patient ID in Electronic Medical Records. A digital readout of the data matrix code can lead to more efficient processes, especially in testing environments
with a high throughput.

SARS-CoV-2 Rapid Antigen Test 2.0​ Nasal characteristics

  • Assay format

    Lateral flow test / immunochromatographic / qualitative

  • Instrument


  • Testing time

    15-30 minutes

  • SARS-CoV-2 Sensitivity*


  • SARS-CoV-2 Specificity*


  • Antigen

    Nucleocapsid protein (N)

  • Sample material

    Nasal swab

  • Reagents

    mAb anti-SARS-CoV-2 antibody, mAb anti-chicken IgY, mAb anti-SARS-CoV-2 antibody‑gold conjugate, Purified chicken IgY‑gold conjugate

*Relative sensitivity and relative specificity are compared to RT-PCR.


  1. Roche Diagnostics. SARS-CoV-2 Rapid Antigen Test 2.0 Nasal, Package Insert 2022-05, V1.0; Relative sensitivity and relative specificity are compared to RT-PCR.


Detailed Specifications

Ordering Information

Compatible Instruments


    Technical Documents

    Access Material Data Sheets, Certificates of Analysis, and other product documentation.

    After clicking below, you will be redirected to eLabDoc, where you can choose your local country.
    error errorMessage
    Sorry, we couldn't find the content you are looking for
    Please try again later